Access to anti-cancer drugs in India: is there a need to revise reimbursement policies?

Expert Review of Pharmacoeconomics & Outcomes Research
Gertruud HaitsmaMaarten J Postma

Abstract

The aim of this study was to examine the access of Indian cancer patients to optimum cancer care under selected government schemes by reviewing reimbursement schemes for cancer care in India. All cancer care reimbursement schemes in India were identified and three highly utilized schemes (VAS, RAS, CMCHS) were selected. Quality of breast, colorectal, lung, head & neck, and gastric cancer care was reviewed with respect to NCCN guidelines. Direct medical costs and shortage of budget in reimbursed amounts were calculated for each listed chemotherapy regimen. Medical oncology practice following the schemes' formularies is inferior to recommendations by the NCCN guidelines. Innovative treatment (targeted therapies) like trastuzumab, pertuzumab (breast), bevacizumab, cetuximab, panitumumab (colorectal), erlotinib, gefitinib, crizotinib, and nivolumab (lung) are either not reimbursed (VAS, CMCHS) or partially reimbursed (RAS). Average shortage of budget was found to be 43% (breast), 55% (colorectal), 74% (lung), 7% (head & neck), and 51% (gastric cancer). Policy makers should consider addition of newer treatments, exclusion of sub-optimal treatments, increments in per patient budget and optimization of supportive care, which may contr...Continue Reading

References

May 20, 2006·Bulletin of the World Health Organization·Xavier Seuba
Apr 4, 2008·Nature·Laura J van't Veer, René Bernards
Mar 15, 2011·Bone Marrow Transplantation·G N BazuayeM Stern
Mar 31, 2012·Lancet·Rajesh DikshitUNKNOWN Million Death Study Collaborators
Apr 27, 2012·Globalization and Health·Michael M EngelgauAjay Mahal
Mar 15, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J FerlayF Bray
Aug 21, 2013·PloS One·Ajay MahalMichael Engelgau
Aug 22, 2013·Health Research Policy and Systems·Narayanan DevadasanBart Criel
Aug 30, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G de L Lopes
Apr 16, 2014·The Lancet Oncology·Mohandas K MallathRichard Sullivan
Apr 16, 2014·The Lancet Oncology·C S PrameshRichard Sullivan
Sep 10, 2014·Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology·Gilberto de Lima Lopes Junior
Aug 12, 2015·The Indian Journal of Medical Research·Vishal R TandonAnnil Mahajan

❮ Previous
Next ❯

Citations

Apr 25, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M NagasakaS-H I Ou
Jun 9, 2020·JCO Global Oncology·Gouri Shankar BhattacharyyaS P Somashekhar
Dec 27, 2019·Seminars in Cancer Biology·Aurora Gonzalez-Fierro, Alfonso Dueñas-González
Oct 16, 2020·Medical Oncology·Aparna NatarajanThangarajan Rajkumar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the National Comprehensive Cancer Network : JNCCN
Randall W BurtNCCN
Journal of the National Comprehensive Cancer Network : JNCCN
Therese B BeversNational Comprehensive Cancer Network
Oncology
D G PfisterNational Comprehensive Cancer Network
© 2022 Meta ULC. All rights reserved